Vitamin D May Lower Liver Cancer Risk

Share this content:

the Cancer Therapy Advisor take:

According to a new study published in Hepatology, vitamin D may decrease the risk for developing hepatocellular carcinoma (HCC), or liver cancer, by almost half. Researchers evaluated 138 participants in the EPIC cohort who developed HCC between 1992 and 2010. Blood vitamin D levels were collected and analyzed. Results showed that, compared with vitamin D levels in the lowest tertile, those in the highest tertile had a 49% reduced risk for HCC. Adjustment for covariates, including time to diagnosis, pre-existing liver damage, and chronic hepatitis B or hepatitis C infection did not alter these results. The researchers noted, however, that although these findings suggest that vitamin D plays a role in the etiology of HCC, the study only demonstrated an association rather than causality. Further investigation is still necessary before drawing other conclusions, they said. 

A VITAL Question: Does Vitamin D Prevent Cancer?
Vitamin D May Lower Liver Cancer Risk
Vitamin D has been shown to play an important role in liver function. Now a new study in Western Europeans shows that vitamin D lowers the risk of developing hepatocellular carcinoma (HCC), the main form of liver cancer. "Despite evidence that vitamin D supports liver health, the association between vitamin D levels and HCC had not been fully examined," said Fedirko, who is also lead author of the study.
READ FULL ARTICLE From Biosciencetechnology

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs